Thierry Verbinnen

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Background.  The pre-existence of minority hepatitis C virus (HCV) variants and their impact on treatment outcome, as well as the persistence of emerging resistant variants posttreatment in patients failing treatment with simeprevir/peginterferon/ribavirin (SMV/PR), were assessed by deep sequencing (DS). Methods.  Population sequencing (PS) and Illumina DS(More)
  • 1